Farhad Kamali
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 40
- Antibiotics Pharmacokinetics and Efficacy 9
- Internal Medicine top 2%
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 8
-
- Hormonal Regulation and Hypertension 17
- Toxicology top 1%
-
- Atrial Fibrillation Management and Outcomes 25
- Blood Pressure and Hypertension Studies 11
-
- Vitamin K Research Studies 13
-
- Pharmacological Effects and Toxicity Studies 9
- Co-authors
- Hilary WynneDorothy Newbury‐BirchPeter AveryAnn K. DalyC. H. AshtonTayyaba KhanPatrick KestevenElizabeth Sconce
- Partner nations
- United KingdomSwedenNetherlands
In The Last Decade
Farhad Kamali
97 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Pharmacology 2.1k
- Internal Medicine 293
- Biochemistry 437
- Endocrinology, Diabetes and Metabolism 779
- Toxicology 146
Countries citing papers authored by Farhad Kamali
This map shows the geographic impact of Farhad Kamali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Kamali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Kamali more than expected).
Fields of papers citing papers by Farhad Kamali
This network shows the impact of papers produced by Farhad Kamali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Kamali. The network helps show where Farhad Kamali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Farhad Kamali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 7 | |
| 2 | 2018 | 4 | |
| 3 | Effect of Statins on Functional Expression of Membrane Transporters in L6 Rat Skeletal Muscle Cells | 2016 | 1 |
| 4 | 2016 | 9 | |
| 5 | 2015 | 58 | |
| 6 | 2014 | 7 | |
| 7 | 2011 | 60 | |
| 8 | 2009 | 55 | |
| 9 | 2006 | 34 | |
| 10 | 2006 | 41 | |
| 11 | 2005 | 73 | |
| 12 | 2004 | 80 | |
| 13 | 2001 | 13 | |
| 14 | 2001 | 147 | |
| 15 | 2000 | 158 | |
| 16 | 1998 | 44 | |
| 17 | 1997 | 29 | |
| 18 | 1995 | 12 | |
| 19 | Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro. | 1995 | 2 |
| 20 | 1994 | 11 |
About Farhad Kamali
Farhad Kamali is a scholar working on Pharmacology, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 99 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (40 papers), Atrial Fibrillation Management and Outcomes (25 papers), Hormonal Regulation and Hypertension (17 papers), Vitamin K Research Studies (13 papers), Blood Pressure and Hypertension Studies (11 papers), Pharmacological Effects and Toxicity Studies (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). The work is most often cited by research in Pharmacology (2.1k citations), Internal Medicine (293 citations) and Biochemistry (437 citations). Farhad Kamali has collaborated with scholars based in United Kingdom, Sweden and Netherlands. Frequent co-authors include Hilary Wynne, Dorothy Newbury‐Birch, Peter Avery, Ann K. Daly, C. H. Ashton, Tayyaba Khan, Patrick Kesteven, Elizabeth Sconce, Peter J. Kelly and Peter Wood. Their work appears in journals such as New England Journal of Medicine, The Lancet and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.